# Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

> **NCT03403530** · PHASE4 · COMPLETED · sponsor: **Sir Takhtasinhji General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Neonatal SEPSIS
- Very Low Birth Weight Baby

## Interventions

- **DRUG:** IgM rich Immunoglobin

## Key facts

- **NCT ID:** NCT03403530
- **Lead sponsor:** Sir Takhtasinhji General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03403530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03403530, "Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03403530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*